Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 3
1967 1
1968 1
1969 1
1970 2
1971 1
1972 2
1973 1
1974 1
1975 1
1976 3
1977 4
1978 2
1980 1
1982 3
1983 4
1984 1
1985 4
1986 10
1987 6
1988 4
1989 6
1990 6
1991 4
1992 7
1993 20
1994 19
1995 18
1996 17
1997 18
1998 41
1999 37
2000 50
2001 51
2002 63
2003 65
2004 85
2005 102
2006 91
2007 119
2008 154
2009 161
2010 191
2011 191
2012 227
2013 224
2014 274
2015 253
2016 221
2017 246
2018 263
2019 229
2020 270
2021 283
2022 302
2023 255
2024 239
2025 270
2026 110

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

4,677 results

Results by year

Filters applied: . Clear all
Page 1
Sotatercept in Patients with Pulmonary Arterial Hypertension at High Risk for Death.
Humbert M, McLaughlin VV, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Preston IR, Souza R, Waxman AB, Moles VM, Savale L, Vizza CD, Rosenkranz S, Shi Y, Miller B, Mackenzie HS, Kim SS, Loureiro MJ, Patel MJ, Koglin J, Cornell AG, Hoeper MM; ZENITH Trial Investigators. Humbert M, et al. Among authors: kim ss. N Engl J Med. 2025 May 29;392(20):1987-2000. doi: 10.1056/NEJMoa2415160. Epub 2025 Mar 31. N Engl J Med. 2025. PMID: 40167274 Clinical Trial.
Sotatercept for Pulmonary Arterial Hypertension within the First Year after Diagnosis.
McLaughlin VV, Hoeper MM, Badesch DB, Ghofrani HA, Gibbs JSR, Gomberg-Maitland M, Preston IR, Souza R, Waxman AB, Kopeć G, Meyer G, Olsson KM, Fu W, Shi Y, Miller B, Kim SS, Mackenzie HS, Brambatti M, Patel MJ, Koglin J, Cornell AG, Humbert M; HYPERION Trial Investigators. McLaughlin VV, et al. Among authors: kim ss. N Engl J Med. 2025 Oct 23;393(16):1599-1611. doi: 10.1056/NEJMoa2508170. Epub 2025 Sep 30. N Engl J Med. 2025. PMID: 41025556 Clinical Trial.
GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma.
Kim HS, Yoon JH, Choi JY, Yoon MG, Baek GO, Kang M, Jang SH, Park W, Go Y, Ng JT, Nam SW, Jeong JY, Han JE, Cho HJ, Lim SB, Kim SS, Cheong JY, Eun JW. Kim HS, et al. Among authors: kim ss. Clin Mol Hepatol. 2025 Jul;31(3):914-934. doi: 10.3350/cmh.2024.1038. Epub 2025 Feb 6. Clin Mol Hepatol. 2025. PMID: 39914372 Free PMC article.
Reply.
Kim Y, Ribarich N, Querques G, Park DH, Kim YJ, Choi EY, Byeon SH, Kim SS, Lee CS. Kim Y, et al. Among authors: kim ss. Retina. 2026 Jun 1;46(6):e64-e66. doi: 10.1097/IAE.0000000000004762. Retina. 2026. PMID: 41490233 No abstract available.
Pelota-mediated ribosome-associated quality control counteracts aging and age-associated pathologies across species.
Lee J, Lee B, Lee H, Kim EJE, Kim SS, Kwon HC, Lee H, Lee GY, Hong W, Ham S, Yang JW, Park H, Moreno TM, Brown ME, Park HH, Kim E, Jung Y, Kang E, Park S, Shin YJ, Ha SG, Kwon S, Hwang S, Min H, Kumsta C, Lim C, Kang C, Seo J, Lee KP, Lee SV. Lee J, et al. Among authors: kim ss. Proc Natl Acad Sci U S A. 2025 Aug 12;122(32):e2505217122. doi: 10.1073/pnas.2505217122. Epub 2025 Aug 4. Proc Natl Acad Sci U S A. 2025. PMID: 40758887 Free PMC article.
4,677 results